The most common pathway identified as conferring risk in glioma are those associated with telomere maintenance, including risk variants near TERT and RTEL1. Many of these SNPs have further molecular subtype associations ([29•]; Table 1). The gene discussed is RTEL1; the disease is central nervous system cancer.